General Description

Plus Therapeutics

Youtube Subscribe

Ticker: PSTV

Sector: Biotechnology

Plus Therapies, Inc. (PSTV) stock price, quote & news - stock analysis. Plus Therapeutics, Inc., a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced pla... Analyst.

Extended Summary

Plus Therapeutics

Plus Therapeutics, Inc. (PSTV) stock price, quote & news - stock analysis. Plus Therapies, Inc., a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced pla... Analyst Consensus: Strong Buy Stock Forecasts. Plus Therapeutics Inc (PSTV) stock is down -9.89% while the S&P 500 is up 0.28% as of 9:57 AM on Monday, Nov 20. Plus Theraputics Inc is down 9.89%, while the S&P 500 is up. Plus Therapeutics granted U.S. FDA Orphan Drug Designation to Rhenium (186Re) Obisbemeda for the Treatment of Breast Cancer with Leptomeningeal Metastases. Plus Therapies granted Orphan drug designation for the treatment of breast cancer.

Related Results

November 25, 2023 3:18 (London Time)